FDA Issues Comprehensive Guidance for Industry and Academic Sponsors Developing Ex Vivo-Manufactured CAR T Cell Products in Oncology: Expert Recommendations for CMC, Pharmacology, and Clinical
Germany Takes the Lead in Cancer Innovation Patents Across Europe ! This is the conclusion of a report published by the European Patent Office on
Fluoropolymers at a Crossroads: A Possible Ban that Shocks the Industry
The amendment of Regulation (EU) 2023/607 opens up new opportunities for those transitioning their medical devices to the MDR. Legacy devices can now have the validity of their directive certificates extended (until the end of 2027/2028, depending on the device classification) if certain conditions are met.
Foundation for the National Institutes of Health (FNIH) Announces AMP BGTC’s Selection of Eight Rare Diseases for Clinical Trials, Paving the Way for Streamlined Gene
Promotion of Authentic Healthcare Innovations and Treatments
Rare Disease Treatment: Exciting Advances in Clinical Research
Unlocking the Power of the 5HT-2A Receptor: Natural Ways to Enhance Mood and Cognition for Optimal Brain Function
The Future of Life Science Research: Targeted Solutions and Collaborative Expertise with REAgency+
REA Research Experts Alliance by Kim Eilitz
E-Mail: success@researchexpertsalliance.agency